LabGenomics Statistics

Total Valuation

LabGenomics has a market cap or net worth of KRW 181.89 billion. The enterprise value is 128.46 billion.

Market Cap	181.89B
Enterprise Value	128.46B

Important Dates

The next estimated earnings date is Friday, March 21, 2025.

Earnings Date	Mar 21, 2025
Ex-Dividend Date	n/a

Share Statistics

LabGenomics has 74.24 million shares outstanding. The number of shares has increased by 2.54% in one year.

Current Share Class	n/a
Shares Outstanding	74.24M
Shares Change (YoY)	+2.54%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.53%
Owned by Institutions (%)	9.21%
Float	61.85M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.12
PB Ratio	0.83
P/TBV Ratio	1.28
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-5.75
EV / Sales	1.50
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-15.06

Financial Position

The company has a current ratio of 1.95, with a Debt / Equity ratio of 0.22.

Current Ratio	1.95
Quick Ratio	1.85
Debt / Equity	0.22
Debt / EBITDA	n/a
Debt / FCF	-5.59
Interest Coverage	-4.33

Financial Efficiency

Return on equity (ROE) is -9.84% and return on invested capital (ROIC) is -5.02%.

Return on Equity (ROE)	-9.84%
Return on Assets (ROA)	-4.46%
Return on Capital (ROIC)	-5.02%
Revenue Per Employee	504.80M
Profits Per Employee	-131.39M
Employee Count	170
Asset Turnover	0.27
Inventory Turnover	20.34

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -41.74% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-41.74%
50-Day Moving Average	2,946.50
200-Day Moving Average	2,880.13
Relative Strength Index (RSI)	39.36
Average Volume (20 Days)	1,434,125

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LabGenomics had revenue of KRW 85.82 billion and -22.34 billion in losses. Loss per share was -301.36.

Revenue	85.82B
Gross Profit	29.28B
Operating Income	-22.70B
Pretax Income	-25.00B
Net Income	-22.34B
EBITDA	-13.04B
EBIT	-22.70B
Loss Per Share	-301.36

Full Income Statement

Balance Sheet

The company has 101.06 billion in cash and 47.63 billion in debt, giving a net cash position of 53.43 billion or 719.72 per share.

Cash & Cash Equivalents	101.06B
Total Debt	47.63B
Net Cash	53.43B
Net Cash Per Share	719.72
Equity (Book Value)	218.63B
Book Value Per Share	2,944.96
Working Capital	70.92B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -4.17 billion and capital expenditures -4.36 billion, giving a free cash flow of -8.53 billion.

Operating Cash Flow	-4.17B
Capital Expenditures	-4.36B
Free Cash Flow	-8.53B
FCF Per Share	-114.88

Full Cash Flow Statement

Margins

Gross margin is 34.12%, with operating and profit margins of -26.45% and -26.03%.

Gross Margin	34.12%
Operating Margin	-26.45%
Pretax Margin	-29.13%
Profit Margin	-26.03%
EBITDA Margin	-15.20%
EBIT Margin	-26.45%
FCF Margin	n/a

Dividends & Yields

LabGenomics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.54%
Shareholder Yield	-2.54%
Earnings Yield	-12.30%
FCF Yield	-4.69%

Dividend Details

Stock Splits

The last stock split was on August 7, 2023. It was a forward split with a ratio of 2.

Last Split Date	Aug 7, 2023
Split Type	Forward
Split Ratio	2

Scores

LabGenomics has an Altman Z-Score of 2.96. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.96
Piotroski F-Score	n/a